1. Home
  2. BOSC vs CRVO Comparison

BOSC vs CRVO Comparison

Compare BOSC & CRVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo B.O.S. Better Online Solutions

BOSC

B.O.S. Better Online Solutions

HOLD

Current Price

$4.57

Market Cap

30.7M

ML Signal

HOLD

Logo CervoMed Inc.

CRVO

CervoMed Inc.

HOLD

Current Price

$3.43

Market Cap

35.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BOSC
CRVO
Founded
1990
2001
Country
Israel
United States
Employees
N/A
N/A
Industry
Computer Communications Equipment
Biotechnology: Pharmaceutical Preparations
Sector
Telecommunications
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
30.7M
35.9M
IPO Year
2002
2011

Fundamental Metrics

Financial Performance
Metric
BOSC
CRVO
Price
$4.57
$3.43
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
6
Target Price
$8.00
$23.00
AVG Volume (30 Days)
53.4K
35.7K
Earning Date
05-28-2026
05-12-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$4,006,510.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$8.97
N/A
Revenue Growth
N/A
N/A
52 Week Low
$3.83
$3.51
52 Week High
$6.72
$13.13

Technical Indicators

Market Signals
Indicator
BOSC
CRVO
Relative Strength Index (RSI) 42.60 33.39
Support Level $4.43 N/A
Resistance Level $4.96 $4.27
Average True Range (ATR) 0.16 0.22
MACD -0.00 -0.01
Stochastic Oscillator 25.00 5.18

Price Performance

Historical Comparison
BOSC
CRVO

About BOSC B.O.S. Better Online Solutions

BOS Better Online Solutions Ltd is a provider of Intelligent Robotics and Supply Chain solutions for enterprises. The company manages its business in three reportable divisions: the Intelligent Robotics segment, the RFID Division segment, and the Supply Chain Solutions segment. The majority of revenue derives from Supply Chain Solutions which distributes electro-mechanical components, mainly to customers in the aerospace, defense, and other industries, and is a supply chain service provider for aviation customers that seek a comprehensive solution to their components-supply needs. Geographically company derives the majority of its revenue from Israel.

About CRVO CervoMed Inc.

CervoMed Inc is a clinical-stage biotechnology company. It is focused on developing treatments for age-related neurologic disorders. The company's product candidate, Neflamapimod, has the potential to treat and improve synaptic dysfunction, the reversible aspect of the underlying disease processes in DLB and certain other neurological disorders.

Share on Social Networks: